Association Between Fecal Bile Acids and Colorectal Cancer: a Meta-analysis of Observational Studies

Overview

Journal Yonsei Med J

Specialty General Medicine

Date 2008 Oct 31

PMID 18972600

Citations 30

Authors

Jin Lu Tong

Zhi Hua Ran

Jun Shen

Guo Quan Fan

Shu Dong Xiao

Affiliations

Soon will be listed here.

Abstract

Purpose: To provide a systematic review with meta-analysis for addressing the relationship between fecal bile acids (FBAs) and colorectal cancer.

Materials And Methods: Electronic databases were searched for all observational studies that examined the relationship between FBAs and colorectal cancer or adenoma, and calculated weighted mean difference (WMD) and 95% confidence interval (CI). Publication bias was assessed with funnel plot.

Results: Twenty case-control or cohort studies were identified. All studies were pooled to assess the relationship between total FBAs and cancer/adenoma of the large bowel, however, no association was seen (WMD 0.61mg/g freeze-dried feces; 95% CI: -0.35-1.57). Significantly increased concentration of chenodeoxycholic acid (CDCA) was seen while pooling to assess the relationship between CDCA and cancer/adenoma of the large bowel (WMD 0.13 mg/g freeze-dried feces; 95% CI: 0.01-0.25), especially for colorectal cancer (WMD 0.28mg/g freeze-dried feces; 95% CI: 0.10-0.46). However, no significant differences in deoxycholic acid (DCA), lithocholic acid (LCA), and primary and secondary bile acids, were seen between patients with cancer and patients with matched controls regardless of fixed and random effects models.

Conclusion: CDCA might play a role in the etiology of colorectal cancer.

Citing Articles

The effect of fecal bile acids on the incidence and risk-stratification of colorectal cancer: an updated systematic review and meta-analysis.

Yang S, Wang Y, Sheng L, Cui W, Ma C Sci Rep. 2025; 15(1):740.

PMID: 39753873 PMC: 11698987. DOI: 10.1038/s41598-024-84801-6.

exacerbates experimental necrotizing enterocolitis via upregulation of the apical sodium-dependent bile acid transporter.

Calton C, Carothers K, Ramamurthy S, Jagadish N, Phanindra B, Garcia A Am J Physiol Gastrointest Liver Physiol. 2023; 326(1):G25-G37.

PMID: 37933481 PMC: 11208032. DOI: 10.1152/ajpgi.00102.2023.

Bile Acids and Microbiota Interplay in Pancreatic Cancer.

Malhotra P, Palanisamy R, Caparros-Martin J, Falasca M Cancers (Basel). 2023; 15(14).

PMID: 37509236 PMC: 10377396. DOI: 10.3390/cancers15143573.

Heterogeneity and lyophilization comparison of stool processing for gastrointestinal bile acid measurement by LC-MS/MS.

Hu C, Wang W, Garey K J Chromatogr B Analyt Technol Biomed Life Sci. 2022; 1214:123569.

PMID: 36527807 PMC: 9839599. DOI: 10.1016/j.jchromb.2022.123569.

Bile acid distributions, sex-specificity, and prognosis in colorectal cancer.

Cai Y, Shen X, Lu L, Yan H, Huang H, Gaule P Biol Sex Differ. 2022; 13(1):61.

PMID: 36274154 PMC: 9590160. DOI: 10.1186/s13293-022-00473-9.

References

Perogambros A, Legakis N . Faecal bile acids in patients with colon cancer. Zentralbl Bakteriol Mikrobiol Hyg B. 1982; 176(4):346-8. View

Kaibara N, Sasaki T, Ikeguchi M, Koga S, Ikawa S . Fecal bile acids and neutral sterols in Japanese with large bowel carcinoma. Oncology. 1983; 40(4):255-8. DOI: 10.1159/000225738. View

Tanida N, Hikasa Y, Shimoyama T, Setchell K . Comparison of faecal bile acid profiles between patients with adenomatous polyps of the large bowel and healthy subjects in Japan. Gut. 1984; 25(8):824-32. PMC: 1432564. DOI: 10.1136/gut.25.8.824. View

Hikasa Y, Tanida N, Ohno T, Shimoyama T . Faecal bile acid profiles in patients with large bowel cancer in Japan. Gut. 1984; 25(8):833-8. PMC: 1432565. DOI: 10.1136/gut.25.8.833. View

Makino T . Fecal bile acid excretion in patients with colon cancer, colon polyp and peptic ulcer. Tokai J Exp Clin Med. 1984; 9(4):297-305. View

Breuer N, Dommes P, Jaekel S, Goebell H . Fecal bile acid excretion pattern in colonic cancer patients. Dig Dis Sci. 1985; 30(9):852-9. DOI: 10.1007/BF01309516. View

Owen R, Henly P, Thompson M, Hill M . Steroids and cancer: faecal bile acid screening for early detection of cancer risk. J Steroid Biochem. 1986; 24(1):391-4. DOI: 10.1016/0022-4731(86)90088-9. View

Breuer N, Jaekel S, Dommes P, Goebell H . Fecal bile acids in patients with adenomatous polyps of the colon. Case-control study. Digestion. 1986; 34(2):87-92. DOI: 10.1159/000199315. View

Owen R, Dodo M, Thompson M, Hill M . Fecal steroids and colorectal cancer. Nutr Cancer. 1987; 9(2-3):73-80. DOI: 10.1080/01635588709513914. View

10.

Hill M, Melville D, Lennard-Jones J, Neale K, Ritchie J . Faecal bile acids, dysplasia, and carcinoma in ulcerative colitis. Lancet. 1987; 2(8552):185-6. DOI: 10.1016/s0140-6736(87)90766-5. View

11.

Korpela J, Adlercreutz H, Turunen M . Fecal free and conjugated bile acids and neutral sterols in vegetarians, omnivores, and patients with colorectal cancer. Scand J Gastroenterol. 1988; 23(3):277-83. DOI: 10.3109/00365528809093865. View

12.

Fearon E, Vogelstein B . A genetic model for colorectal tumorigenesis. Cell. 1990; 61(5):759-67. DOI: 10.1016/0092-8674(90)90186-i. View

13.

Owen R, Day D, Thompson M . Faecal steroids and colorectal cancer: steroid profiles in subjects with adenomatous polyps of the large bowel. Eur J Cancer Prev. 1992; 1(2):105-12. View

14.

Bayerdorffer E, Mannes G, Richter W, Ochsenkuhn T, WIEBECKE B, Kopcke W . Increased serum deoxycholic acid levels in men with colorectal adenomas. Gastroenterology. 1993; 104(1):145-51. DOI: 10.1016/0016-5085(93)90846-5. View

15.

Sandler R . Epidemiology and risk factors for colorectal cancer. Gastroenterol Clin North Am. 1996; 25(4):717-35. DOI: 10.1016/s0889-8553(05)70271-5. View

16.

Kishida T, Taguchi F, Feng L, Tatsuguchi A, Sato J, Fujimori S . Analysis of bile acids in colon residual liquid or fecal material in patients with colorectal neoplasia and control subjects. J Gastroenterol. 1997; 32(3):306-11. DOI: 10.1007/BF02934485. View

17.

Kamano T, Mikami Y, Kurasawa T, Tsurumaru M, Matsumoto M, Kano M . Ratio of primary and secondary bile acids in feces: possible marker for colorectal cancer?. Dis Colon Rectum. 1999; 42(5):668-72. DOI: 10.1007/BF02234147. View

18.

Boutron-Ruault M, Marteau P, Lavergne-Slove A, Myara A, Gerhardt M, Franchisseur C . Effects of a 3-mo consumption of short-chain fructo-oligosaccharides on parameters of colorectal carcinogenesis in patients with or without small or large colorectal adenomas. Nutr Cancer. 2006; 53(2):160-8. DOI: 10.1207/s15327914nc5302_5. View

19.

Soma T, Kaganoi J, Kawabe A, Kondo K, Tsunoda S, Imamura M . Chenodeoxycholic acid stimulates the progression of human esophageal cancer cells: A possible mechanism of angiogenesis in patients with esophageal cancer. Int J Cancer. 2006; 119(4):771-82. DOI: 10.1002/ijc.21917. View

20.

Haines A, Hill M, Thompson M, Owen R, Williams R, Meade T . A prospective study of faecal bile acids and colorectal cancer. Eur J Cancer Prev. 2000; 9(5):317-23. DOI: 10.1097/00008469-200010000-00005. View